Avience Biomedicals IPO: Check GMP, price band and other details (opens original article in a new tab)

Avience Biomedicals, a molecular diagnostics manufacturer, is launching an IPO with a price band of Rs 196-208 per share, featuring a 36% grey market premium and plans to use funds for new manufacturing and working capital.

• Avience Biomedicals IPO opens for subscription on Thursday with a price band of Rs 196-208 per share.
• Grey market premium stands at 36% with unofficial price at Rs 283 per share, indicating strong investor demand.
• IPO proceeds will fund a new manufacturing unit and working capital, with 14,53,800 fresh shares issued.